Cargando…
Todas las empresas de aquí pasadas por las mismas cinco comprobaciones sobre crecimiento y generación de caja. Describe la industria tal como se declara hoy, no cuál de estas comprar.
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | 136,5B US$ | 538,53 US$ | 34,68 | 13B US$ | 30,7 % |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | 100,9B US$ | 955,80 US$ | 21,10 | 16,9B US$ | 28,5 % |
| MRNA | Moderna, Inc. | C- | 90,3B US$ | 223,22 US$ | — | 2,5B US$ | -110,5 % |
| ARGX | ARGENX SE | sin calificar | 59,4B US$ | 959,78 US$ | 49,04 | — | — |
| ONC | BEONE MEDICINES LTD. | A+ | 47,6B US$ | 416,41 US$ | 53,39 | 6,6B US$ | 13,9 % |
| RPRX | Royalty Pharma plc | C+ | 39,8B US$ | 69,30 US$ | 45,29 | 2,6B US$ | 25,7 % |
| RVMD | Revolution Medicines, Inc. | F | 37,3B US$ | 172,27 US$ | — | 0,00 US$ | — |
| ROIV | ROIVANT SCIENCES LTD. | B- | 28,6B US$ | 39,54 US$ | — | 41,1M US$ | -838,2 % |
| INSM | INSMED INC | C- | 26,6B US$ | 121,15 US$ | — | 1,5B US$ | -39,9 % |
| INCY | INCYTE CORPORATION | C | 24,7B US$ | 120,94 US$ | 64,33 | 6B US$ | 6,7 % |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | B+ | 22,1B US$ | 165,05 US$ | 70,84 | 3,7B US$ | 71,3 % |
| BNTX | BioNTech SE | F | 21,5B US$ | 85,57 US$ | — | 2,7B US$ | -60,9 % |
| NCNA | NUCANA PLC | sin calificar | 18,5B US$ | 0,89 US$ | — | — | — |
| ASND | Ascendis Pharma A/S | D | 17,1B US$ | 275,33 US$ | — | 1,3B US$ | -19,0 % |
| EXEL | EXELIXIS, INC. | A+ | 16,8B US$ | 68,99 US$ | 20,66 | 2,5B US$ | 35,5 % |
| JAZZ | Jazz Pharmaceuticals plc | A | 15,5B US$ | 241,38 US$ | 78,63 | 4,7B US$ | 4,4 % |
| BBIO | BridgeBio Pharma, Inc. | B | 15,3B US$ | 78,31 US$ | — | 945,5M US$ | -60,7 % |
| AKTX | Akari Therapeutics, Plc | sin calificar | 12,7B US$ | 6,85 US$ | — | — | — |
| TECH | BIO-TECHNE Corp | A+ | 11,4B US$ | 72,80 US$ | 66,79 | 1,2B US$ | 14,0 % |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | 11,4B US$ | 100,30 US$ | 25,01 | 1,8B US$ | 26,9 % |
| SMMT | Summit Therapeutics Inc. | sin calificar | 11,3B US$ | 14,14 US$ | — | — | — |
| BMRN | BioMarin Pharmaceutical Inc | B | 11,1B US$ | 57,22 US$ | — | 3,7B US$ | -0,5 % |
| KYMR | KYMERA THERAPEUTICS, INC. | F- | 10,9B US$ | 127,63 US$ | — | 102,2M US$ | -341,8 % |
| PCVX | VAXCYTE, INC. | sin calificar | 10B US$ | 63,36 US$ | — | — | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | B- | 9,9B US$ | 427,50 US$ | — | 1,4B US$ | -10,9 % |
| SYRE | SPYRE THERAPEUTICS, INC. | D | 9,9B US$ | 104,01 US$ | — | 0,00 US$ | — |
| TGTX | TG THERAPEUTICS, INC. | A+ | 9,7B US$ | 64,49 US$ | 96,25 | 897,8M US$ | 11,8 % |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | 9,2B US$ | 327,93 US$ | — | 0,00 US$ | — |
| KRYS | Krystal Biotech, Inc. | A+ | 9B US$ | 304,96 US$ | 41,38 | 470M US$ | 47,9 % |
| PTGX | PROTAGONIST THERAPEUTICS, INC. | A+ | 8,5B US$ | 130,83 US$ | 27,78 | 551,7M US$ | 62,0 % |
| CORT | CORCEPT THERAPEUTICS INC | A+ | 8B US$ | 72,94 US$ | 57,43 | 963,6M US$ | 16,8 % |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | 8B US$ | 115,03 US$ | — | 280,7M US$ | -69,0 % |
| CYTK | CYTOKINETICS, INCORPORATED | D | 7,8B US$ | 56,14 US$ | — | 113,3M US$ | -686,6 % |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | 7,4B US$ | 141,54 US$ | — | 865,3M US$ | -18,2 % |
| KOD | KODIAK SCIENCES INC. | sin calificar | 7,3B US$ | 111,19 US$ | — | — | — |
| ORKA | Oruka Therapeutics, Inc. | sin calificar | 7,1B US$ | 105,34 US$ | — | — | — |
| IMVT | Immunovant, Inc. | sin calificar | 7,1B US$ | 34,19 US$ | — | — | — |
| TWST | Twist Bioscience Corporation | C- | 7B US$ | 111,56 US$ | — | 459,4M US$ | -28,3 % |
| ABVX | Abivax S.A. | sin calificar | 6,9B US$ | 87,63 US$ | — | — | — |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | F- | 6,8B US$ | 47,77 US$ | — | 450,8M US$ | -160,6 % |
| CGON | CG Oncology, Inc. | F- | 6,6B US$ | 74,35 US$ | — | 6,2M US$ | -3851,1 % |
| CAI | CARIS LIFE SCIENCES, INC. | A | 6,6B US$ | 23,05 US$ | 13,89 | 1B US$ | 9,2 % |
| BLTE | Belite Bio, Inc | sin calificar | 6,5B US$ | 164,03 US$ | — | — | — |
| IBRX | IMMUNITYBIO, INC. | C | 6,4B US$ | 6,01 US$ | — | 182,6M US$ | -607,8 % |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | C | 6,2B US$ | 309,05 US$ | 134,37 | 253,8M US$ | 20,3 % |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | 6,1B US$ | 94,00 US$ | — | 670,8M US$ | -134,8 % |
| ERAS | ERASCA, INC. | sin calificar | 5,5B US$ | 15,65 US$ | — | — | — |
| MANE | Veradermics, Inc | sin calificar | 5,5B US$ | 129,60 US$ | — | — | — |
| PTCT | PTC Therapeutics, Inc. | D | 5,3B US$ | 63,49 US$ | — | 1,2B US$ | -9,2 % |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F- | 5,3B US$ | 43,16 US$ | — | 570K US$ | -72.563,2 % |
| DNTH | Dianthus Therapeutics, Inc. | F- | 5,2B US$ | 91,76 US$ | — | 2M US$ | -9927,5 % |
| EWTX | Edgewise Therapeutics, Inc. | sin calificar | 5B US$ | 45,97 US$ | 5,62 | — | — |
| COGT | Cogent Biosciences, Inc. | sin calificar | 5B US$ | 28,53 US$ | — | — | — |
| TVTX | TRAVERE THERAPEUTICS, INC. | F- | 4,9B US$ | 50,63 US$ | — | 651M US$ | -18,7 % |
| IONS | IONIS PHARMACEUTICALS, INC. | F- | 4,8B US$ | 29,06 US$ | — | 960,1M US$ | -56,9 % |
| DFTX | Definium Therapeutics, Inc. | sin calificar | 4,4B US$ | 32,09 US$ | — | — | — |
| TNGX | TANGO THERAPEUTICS, INC. | F | 4,3B US$ | 25,52 US$ | — | 0,00 US$ | — |
| GPCR | Structure Therapeutics Inc. | sin calificar | 4,3B US$ | 20,01 US$ | — | — | — |
| CRSP | CRISPR THERAPEUTICS AG | F- | 4,1B US$ | 42,21 US$ | — | 25,2M US$ | -1812,1 % |
| ZLAB | ZAI LAB LIMITED | F- | 4B US$ | 24,61 US$ | — | 441,7M US$ | -44,9 % |
| RLAY | RELAY THERAPEUTICS, INC. | D- | 4B US$ | 18,10 US$ | — | 10,4M US$ | -2837,0 % |
| XENE | Xenon Pharmaceuticals Inc. | F | 4B US$ | 40,49 US$ | — | 0,00 US$ | — |
| TARS | TARSUS PHARMACEUTICALS, INC. | B- | 4B US$ | 80,25 US$ | — | 682,2M US$ | -102,9 % |
| ABCL | AbCellera Biologics Inc. | C- | 3,8B US$ | 11,49 US$ | — | 67,9M US$ | -218,5 % |
| VKTX | VIKING THERAPEUTICS, INC. | F | 3,7B US$ | 29,25 US$ | — | 0,00 US$ | — |
| IRON | Disc Medicine, Inc. | sin calificar | 3,6B US$ | 80,00 US$ | — | — | — |
| ELVN | ENLIVEN THERAPEUTICS, INC. | sin calificar | 3,6B US$ | 48,77 US$ | — | — | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | 3,6B US$ | 7,75 US$ | — | 379M US$ | -58,2 % |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | B | 3,6B US$ | 28,25 US$ | 134,52 | 508,7M US$ | 5,9 % |
| PBLS | Parabilis Medicines, Inc. | sin calificar | 3,6B US$ | 28,44 US$ | — | — | — |
| VRDN | Viridian Therapeutics, Inc./DE | F- | 3,5B US$ | 30,86 US$ | — | 26,3M US$ | -1724,1 % |
| DBVT | DBV TECHNOLOGIES S.A. | F- | 3,5B US$ | 11,07 US$ | — | 3,8M US$ | -5405,3 % |
| ACAD | ACADIA PHARMACEUTICALS INC. | B+ | 3,2B US$ | 18,73 US$ | 8,83 | 1,2B US$ | 30,1 % |
| LEGN | Legend Biotech Corp | C- | 3,2B US$ | 17,49 US$ | — | 1,1B US$ | -22,0 % |
| GMAB | Genmab A/S | B+ | 3,2B US$ | 51,36 US$ | 3,34 | 3,9B US$ | 21,0 % |
| DYN | Dyne Therapeutics, Inc. | sin calificar | 3,2B US$ | 17,17 US$ | — | — | — |
| CELC | CELCUITY INC. | sin calificar | 3,2B US$ | 64,32 US$ | — | — | — |
| TLX | Telix Pharmaceuticals Limited | D | 3,1B US$ | 9,23 US$ | — | 890,8M US$ | 3,8 % |
| IDYA | IDEAYA Biosciences, Inc. | F- | 3,1B US$ | 31,82 US$ | — | 36,5M US$ | -1149,6 % |
| ADMA | ADMA BIOLOGICS, INC. | B+ | 3B US$ | 13,69 US$ | 17,78 | 519,2M US$ | 35,1 % |
| DNLI | Denali Therapeutics Inc. | F | 3B US$ | 18,74 US$ | — | 0,00 US$ | — |
| VCEL | VERICEL CORPORATION | A | 2,9B US$ | 56,96 US$ | 89,00 | 324,2M US$ | 10,3 % |
| XNCR | Xencor, Inc | D- | 2,8B US$ | 37,08 US$ | — | 200,5M US$ | -58,8 % |
| MBX | MBX Biosciences, Inc. | sin calificar | 2,8B US$ | 55,98 US$ | — | — | — |
| RCUS | Arcus Biosciences, Inc. | F- | 2,5B US$ | 17,43 US$ | — | 100M US$ | -453,0 % |
| NAMS | NewAmsterdam Pharma Company N.V. | D- | 2,4B US$ | 20,16 US$ | — | 25,9M US$ | -789,9 % |
| BEAM | Beam Therapeutics Inc. | F- | 2,4B US$ | 22,82 US$ | — | 146,6M US$ | -73,9 % |
| CLDX | Celldex Therapeutics, Inc. | F- | 2,3B US$ | 28,82 US$ | — | 158K US$ | -195.608,9 % |
| LKFT | GALAPAGOS NV | D | 2,2B US$ | 33,95 US$ | 6,31 | 1,2B US$ | 28,9 % |
| PVLA | Palvella Therapeutics, Inc. | sin calificar | 2,2B US$ | 152,51 US$ | — | — | — |
| IMNM | Immunome Inc. | F | 2,2B US$ | 18,74 US$ | — | 0,00 US$ | — |
| PHVS | Pharvaris N.V. | sin calificar | 2,2B US$ | 33,37 US$ | — | — | — |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | 2,1B US$ | 15,73 US$ | 6,87 | 321,7M US$ | 97,7 % |
| BHVN | Biohaven Ltd. | sin calificar | 2,1B US$ | 13,81 US$ | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | sin calificar | 2,1B US$ | 21,90 US$ | — | — | — |
| VERA | Vera Therapeutics, Inc. | sin calificar | 2B US$ | 28,11 US$ | — | — | — |
| SEPN | Septerna, Inc. | F- | 2B US$ | 42,61 US$ | — | 96,3M US$ | -61,3 % |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | B+ | 2B US$ | 33,76 US$ | 11,14 | 989,4M US$ | 18,1 % |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | sin calificar | 2B US$ | 47,15 US$ | — | — | — |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | 2B US$ | 3,18 US$ | — | 68,2M US$ | -697,1 % |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | 2B US$ | 7,54 US$ | — | 213M US$ | -30,8 % |
| FTRE | Fortrea Holdings Inc. | C | 1,9B US$ | 20,20 US$ | — | 2,7B US$ | -2,6 % |
| TRVI | TREVI THERAPEUTICS, INC. | sin calificar | 1,9B US$ | 13,65 US$ | — | — | — |
| COAG | Hemab Therapeutics Holdings, Inc. | sin calificar | 1,9B US$ | 40,79 US$ | — | — | — |
| ZBIO | Zenas BioPharma, Inc. | F- | 1,9B US$ | 27,99 US$ | — | 10M US$ | -5418,1 % |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | 1,9B US$ | 31,57 US$ | — | 140,8M US$ | -264,8 % |
| MAZE | MAZE THERAPEUTICS, INC. | sin calificar | 1,9B US$ | 34,29 US$ | — | — | — |
| ZYME | ZYMEWORKS INC. | F+ | 1,8B US$ | 26,24 US$ | 50,46 | 266M US$ | 16,3 % |
| BRVE | Braveheart Bio, Inc. | sin calificar | 1,8B US$ | 19,67 US$ | — | — | — |
| STOK | Stoke Therapeutics, Inc. | F- | 1,7B US$ | 26,66 US$ | — | 28,2M US$ | -862,1 % |
| SRPT | SAREPTA THERAPEUTICS, INC. | C | 1,7B US$ | 16,07 US$ | — | 2B US$ | -5,9 % |
| KLRA | Kailera Therapeutics, Inc. | sin calificar | 1,7B US$ | 13,26 US$ | — | — | — |
| MESO | MESOBLAST LIMITED | C- | 1,7B US$ | 13,25 US$ | — | 65,4M US$ | -144,3 % |
| VIR | Vir Biotechnology, Inc. | C- | 1,7B US$ | 9,96 US$ | — | 302,8M US$ | -61,0 % |
| NRIX | NURIX THERAPEUTICS, INC. | A+ | 1,7B US$ | 15,47 US$ | 6,72 | 701,9M US$ | 42,0 % |
| QURE | uniQure N.V. | F- | 1,7B US$ | 23,84 US$ | — | 20,2M US$ | -1154,8 % |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | 1,6B US$ | 16,07 US$ | — | 730M US$ | -71,8 % |
| PGEN | PRECIGEN, INC. | C | 1,6B US$ | 4,52 US$ | 45,20 | 156,9M US$ | 15,6 % |
| SLS | SELLAS Life Sciences Group, Inc. | sin calificar | 1,6B US$ | 7,87 US$ | — | — | — |
| GENB | Generate Biomedicines, Inc. | sin calificar | 1,6B US$ | 12,06 US$ | — | — | — |
| RAPP | Rapport Therapeutics, Inc. | sin calificar | 1,6B US$ | 26,16 US$ | — | — | — |
| IMCR | Immunocore Holdings plc | F- | 1,5B US$ | 29,99 US$ | — | 429,3M US$ | -7,5 % |
| NBTX | Nanobiotix S.A. | C- | 1,5B US$ | 30,34 US$ | — | 36,4M US$ | -73,5 % |
| ABSI | ABSCI CORP | F- | 1,5B US$ | 8,45 US$ | — | 1,5M US$ | -8451,3 % |
| NUVB | Nuvation Bio Inc. | C- | 1,4B US$ | 3,99 US$ | — | 201,7M US$ | -67,4 % |
| NVAX | NOVAVAX, INC. | F | 1,4B US$ | 8,53 US$ | — | 411,6M US$ | -18,6 % |
| LBRX | LB Pharmaceuticals Inc | sin calificar | 1,4B US$ | 42,93 US$ | — | — | — |
| TYRA | TYRA BIOSCIENCES, INC. | sin calificar | 1,4B US$ | 20,03 US$ | — | — | — |
| ANAB | ANAPTYSBIO, INC. | D+ | 1,4B US$ | 46,26 US$ | 8,68 | 191,6M US$ | 96,3 % |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | D- | 1,4B US$ | 14,71 US$ | — | 96,6M US$ | -193,4 % |
| OCUL | OCULAR THERAPEUTIX, INC | F- | 1,4B US$ | 6,20 US$ | — | 50,4M US$ | -648,6 % |
| NTLA | INTELLIA THERAPEUTICS, INC. | D- | 1,4B US$ | 9,70 US$ | — | 52,9M US$ | -805,7 % |
| MLYS | MINERALYS THERAPEUTICS, INC. | sin calificar | 1,4B US$ | 15,32 US$ | — | — | — |
| INVA | INNOVIVA, INC. | C+ | 1,4B US$ | 19,03 US$ | 9,51 | 438,3M US$ | 44,1 % |
| AVLN | Avalyn Pharma Inc. | sin calificar | 1,3B US$ | 30,26 US$ | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | sin calificar | 1,3B US$ | 21,61 US$ | — | — | — |
| TSHA | Taysha Gene Therapies, Inc. | F- | 1,3B US$ | 4,09 US$ | — | 5,5M US$ | -2844,6 % |
| MNKD | MannKind Corporation | D | 1,3B US$ | 4,12 US$ | — | 413,4M US$ | -18,1 % |
| KARD | Kardigan, Inc. | sin calificar | 1,3B US$ | 13,83 US$ | — | — | — |
| URGN | UroGen Pharma Ltd. | C | 1,3B US$ | 26,18 US$ | — | 250,3M US$ | -26,3 % |
| NKTR | NEKTAR THERAPEUTICS | F- | 1,3B US$ | 37,29 US$ | — | 52,2M US$ | -339,7 % |
| OMER | OMEROS CORP | sin calificar | 1,3B US$ | 17,49 US$ | 10,17 | — | — |
| SLN | Silence Therapeutics plc | F- | 1,2B US$ | 19,84 US$ | — | 456K US$ | -11.276,5 % |
| INBX | Inhibrx Biosciences, Inc. | D- | 1,2B US$ | 83,17 US$ | — | 1,3M US$ | -10.896,8 % |
| VOR | Vor Biopharma Inc. | sin calificar | 1,2B US$ | 19,42 US$ | 0,06 | — | — |
| ANRO | Alto Neuroscience, Inc. | sin calificar | 1,2B US$ | 29,66 US$ | — | — | — |
| GHRS | GH Research PLC | sin calificar | 1,2B US$ | 19,17 US$ | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | sin calificar | 1,2B US$ | 13,37 US$ | — | — | — |
| JBIO | Jade Biosciences, Inc. | sin calificar | 1,1B US$ | 16,13 US$ | — | — | — |
| SGP | SpyGlass Pharma, Inc. | sin calificar | 1,1B US$ | 32,93 US$ | — | — | — |
| SPTX | Seaport Therapeutics, Inc. | sin calificar | 1,1B US$ | 19,93 US$ | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | sin calificar | 1,1B US$ | 12,51 US$ | — | — | — |
| VSTM | Verastem, Inc. | F- | 1B US$ | 8,19 US$ | — | 100,3M US$ | -178,4 % |
| SVRA | Savara Inc. | sin calificar | 1B US$ | 4,64 US$ | — | — | — |
| AKTS | Aktis Oncology, Inc. | sin calificar | 928,5M US$ | 16,64 US$ | — | — | — |
| ODTX | Odyssey Therapeutics, Inc. | sin calificar | 918,1M US$ | 19,10 US$ | — | — | — |
| PHAR | Pharming Group N.V. | A | 912,9M US$ | 13,01 US$ | 325,25 | 376,1M US$ | 0,8 % |
| MGTX | MeiraGTx Holdings plc | B | 898,6M US$ | 9,20 US$ | 11,49 | 401,9M US$ | 19,5 % |
| CRVS | Corvus Pharmaceuticals, Inc. | sin calificar | 896,7M US$ | 10,63 US$ | — | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | 884,5M US$ | 12,22 US$ | — | 96,1M US$ | -208,6 % |
| LTGO | Latigo Biotherapeutics, Inc. | sin calificar | 872,2M US$ | 13,16 US$ | — | — | — |
| IMTX | Immatics N.V. | sin calificar | 857,4M US$ | 6,40 US$ | — | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | 843M US$ | 9,44 US$ | — | 289,7M US$ | -72,3 % |
| RIGL | RIGEL PHARMACEUTICALS INC | B+ | 838,9M US$ | 44,55 US$ | 2,77 | 288,2M US$ | 106,6 % |
| ORIC | ORIC PHARMACEUTICALS, INC. | sin calificar | 811,6M US$ | 7,83 US$ | — | — | — |
| ANNX | ANNEXON, INC. | sin calificar | 807,7M US$ | 3,93 US$ | — | — | — |
| LXRX | Lexicon Pharmaceuticals, Inc. | D- | 801,4M US$ | 1,80 US$ | — | 38,5M US$ | -161,8 % |
| GLUE | Monte Rosa Therapeutics, Inc. | F- | 800,7M US$ | 9,37 US$ | — | 70,3M US$ | -186,2 % |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | 777,1M US$ | 12,58 US$ | — | 0,00 US$ | — |
| ARDX | ARDELYX, INC. | C- | 774,2M US$ | 3,08 US$ | — | 468,2M US$ | -11,8 % |
| PRME | Prime Medicine, Inc. | B- | 774,1M US$ | 4,26 US$ | — | 4,6M US$ | -3807,3 % |
| SLDB | Solid Biosciences Inc. | sin calificar | 763,4M US$ | 6,84 US$ | — | — | — |
| ACHV | Achieve Life Sciences, Inc. | sin calificar | 747,1M US$ | 6,79 US$ | — | — | — |
| AURA | AURA BIOSCIENCES, INC. | sin calificar | 740M US$ | 7,11 US$ | — | — | — |
| SGMT | Sagimet Biosciences Inc. | sin calificar | 729,4M US$ | 10,22 US$ | — | — | — |
| ALMS | Alumis Inc. | F- | 725,7M US$ | 5,59 US$ | — | 7,2M US$ | -5844,5 % |
| OABI | OMNIAB, INC. | B | 715,4M US$ | 4,91 US$ | — | 40,2M US$ | -108,1 % |
| KURA | Kura Oncology, Inc. | C- | 713,4M US$ | 7,77 US$ | — | 79,3M US$ | -369,3 % |
| IVA | Inventiva S.A. | F | 711,1M US$ | 3,68 US$ | — | 5M US$ | -7899,6 % |
| APMD | Apnimed, Inc. | sin calificar | 705,4M US$ | 16,95 US$ | — | — | — |
| NVCT | NUVECTIS PHARMA, INC. | sin calificar | 697,4M US$ | 20,28 US$ | — | — | — |
| JANX | Janux Therapeutics, Inc. | C- | 695M US$ | 11,36 US$ | — | 23,3M US$ | -428,7 % |
| ATTO | Attovia Therapeutics, Inc. | sin calificar | 693,9M US$ | 15,18 US$ | — | — | — |
| AVBP | ARRIVENT BIOPHARMA, INC. | sin calificar | 673,4M US$ | 13,02 US$ | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | 670,8M US$ | 10,48 US$ | — | 0,00 US$ | — |
| CGEM | CULLINAN THERAPEUTICS, INC. | sin calificar | 667,1M US$ | 10,28 US$ | — | — | — |
| BCAX | BICARA THERAPEUTICS INC. | sin calificar | 665,9M US$ | 10,03 US$ | — | — | — |
| OLMA | OLEMA PHARMACEUTICALS, INC. | sin calificar | 660,6M US$ | 7,54 US$ | — | — | — |
| IMMX | IMMIX BIOPHARMA, INC. | sin calificar | 656,3M US$ | 7,83 US$ | — | — | — |
| ABUS | ARBUTUS BIOPHARMA CORP | D+ | 627M US$ | 4,09 US$ | 3,62 | 181,5M US$ | 121,2 % |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | F- | 623M US$ | 9,61 US$ | — | 130,8M US$ | -192,0 % |
| ACRS | Aclaris Therapeutics, Inc. | F- | 621,8M US$ | 3,92 US$ | — | 6,4M US$ | -1244,1 % |
| GERN | GERON CORP | sin calificar | 618,5M US$ | 0,96 US$ | — | — | — |
| WVE | WAVE LIFE SCIENCES, INC. | F- | 618,3M US$ | 3,14 US$ | — | 70,9M US$ | -296,9 % |
| CLYM | Climb Bio, Inc. | sin calificar | 607,9M US$ | 10,35 US$ | — | — | — |
| SANA | Sana Biotechnology, Inc. | sin calificar | 603,8M US$ | 2,02 US$ | — | — | — |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | 569M US$ | 7,23 US$ | — | 31,2M US$ | -182,5 % |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | 553,8M US$ | 9,53 US$ | — | 0,00 US$ | — |
| CBIO | Crescent Biopharma, Inc. | D- | 553,5M US$ | 14,23 US$ | — | 15M US$ | -727,6 % |
| ENTX | ENTERA BIO LTD. | F | 545,1M US$ | 3,13 US$ | — | 0,00 US$ | — |
| ZVRA | Zevra Therapeutics, Inc. | B+ | 539,1M US$ | 9,06 US$ | 7,61 | 147,8M US$ | 52,8 % |
| RGNX | REGENXBIO Inc. | F- | 505,2M US$ | 7,64 US$ | — | 153,9M US$ | -113,9 % |
| GYRE | Gyre Therapeutics, Inc. | F- | 495,9M US$ | 4,30 US$ | — | 108,1M US$ | -33,9 % |
| NGNE | Neurogene Inc. | F | 495M US$ | 23,91 US$ | — | 0,00 US$ | — |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | 494,3M US$ | 6,08 US$ | — | 274,9M US$ | -30,2 % |
| VALN | Valneva SE | F- | 491,1M US$ | 5,66 US$ | — | 174,7M US$ | -73,7 % |
| MNPR | Monopar Therapeutics Inc. | F | 488,4M US$ | 72,07 US$ | — | 0,00 US$ | — |
| CADL | CANDEL THERAPEUTICS, INC. | sin calificar | 486,4M US$ | 6,20 US$ | — | — | — |
| INDP | Indaptus Therapeutics, Inc. | sin calificar | 485,4M US$ | 3,16 US$ | — | — | — |
| DMAC | DIAMEDICA THERAPEUTICS INC. | sin calificar | 475,1M US$ | 8,81 US$ | — | — | — |
| STTK | Shattuck Labs, Inc. | F | 472,5M US$ | 4,64 US$ | — | 0,00 US$ | — |
| MDXG | MIMEDX GROUP, INC. | F | 468,4M US$ | 3,21 US$ | — | 303,7M US$ | -6,3 % |
| JSPR | Jasper Therapeutics, Inc. | sin calificar | 454,9M US$ | 13,67 US$ | — | — | — |
| RLMD | RELMADA THERAPEUTICS, INC. | sin calificar | 450,3M US$ | 4,22 US$ | — | — | — |
| AVTX | AVALO THERAPEUTICS, INC. | F- | 448,1M US$ | 7,75 US$ | — | 59K US$ | -150.259,3 % |
| BLSM | BlossomHill Therapeutics, Inc. | sin calificar | 447,2M US$ | 14,07 US$ | — | — | — |
| ARVN | ARVINAS, INC. | C- | 446,6M US$ | 6,82 US$ | — | 275,3M US$ | -3,5 % |
| CTMX | CytomX Therapeutics, Inc. | F- | 443,6M US$ | 2,04 US$ | — | 14M US$ | -609,0 % |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | C- | 433,1M US$ | 21,15 US$ | — | 72,3M US$ | -15,4 % |
| IRLA | IRulya Therapeutics Inc. | sin calificar | 431,3M US$ | 39,78 US$ | — | — | — |
| KRSA | Korsana Biosciences, Inc. | F | 426,1M US$ | 31,50 US$ | — | 1,9M US$ | -3098,7 % |
| TECX | TECTONIC THERAPEUTIC, INC. | sin calificar | 419,7M US$ | 21,04 US$ | — | — | — |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | D- | 419,5M US$ | 8,17 US$ | — | 52,7M US$ | -45,4 % |
| FENC | FENNEC PHARMACEUTICALS INC. | A | 411,1M US$ | 11,65 US$ | 582,25 | 66,4M US$ | 3,1 % |
| OCS | Oculis Holding AG | sin calificar | 401,2M US$ | 7,68 US$ | — | — | — |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | 401,2M US$ | 7,76 US$ | 16,87 | 231,8M US$ | 10,3 % |
| SPRY | ARS Pharmaceuticals, Inc. | F- | 392,1M US$ | 3,90 US$ | — | 122,1M US$ | -163,6 % |
| IRD | Opus Genetics, Inc. | F- | 385,7M US$ | 3,99 US$ | — | 7,9M US$ | -1726,7 % |
| ALEC | Alector, Inc. | B+ | 379,6M US$ | 2,55 US$ | 7,29 | 173,5M US$ | 23,9 % |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | sin calificar | 371,9M US$ | 1,72 US$ | — | — | — |
| CRMD | CORMEDIX INC. | B+ | 370,2M US$ | 4,66 US$ | 7,76 | 412,5M US$ | 15,5 % |
| CCCC | C4 Therapeutics, Inc. | D- | 363,1M US$ | 2,77 US$ | — | 32,3M US$ | -282,2 % |
| RZLT | Rezolute, Inc. | sin calificar | 353,1M US$ | 3,65 US$ | — | — | — |
| LYEL | Lyell Immunopharma, Inc. | F- | 350,6M US$ | 14,26 US$ | — | 15K US$ | -1.701.066,7 % |
| AVIR | Atea Pharmaceuticals, Inc. | sin calificar | 345,3M US$ | 4,30 US$ | — | — | — |
| YDES | YD Bio Limited | D | 345,1M US$ | 4,88 US$ | — | 596,8K US$ | -1392,6 % |
| ANL | Adlai Nortye Ltd. | C | 341,2M US$ | 10,67 US$ | — | 5M US$ | -710,6 % |
| EDIT | EDITAS MEDICINE, INC. | B- | 334,1M US$ | 2,17 US$ | — | 49,8M US$ | -145,0 % |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | 326M US$ | 8,16 US$ | — | 0,00 US$ | — |
| BNTC | BENITEC BIOPHARMA INC. | D | 325,8M US$ | 9,02 US$ | — | 0,00 US$ | — |
| IMUX | Immunic, Inc. | sin calificar | 323,5M US$ | 7,56 US$ | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | sin calificar | 322,9M US$ | 5,96 US$ | — | — | — |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | 319,8M US$ | 10,98 US$ | — | 65,3M US$ | -96,9 % |
| KYTX | Kyverna Therapeutics, Inc. | sin calificar | 319,3M US$ | 5,05 US$ | — | — | — |
| ALT | ALTIMMUNE, INC. | D- | 319,1M US$ | 1,64 US$ | — | 41K US$ | -254.522,0 % |
| XFOR | X4 PHARMACEUTICALS, INC | D- | 318,6M US$ | 3,12 US$ | — | 17M US$ | -474,7 % |
| EVMN | Evommune, Inc. | F | 315,5M US$ | 7,63 US$ | — | 0,00 US$ | — |
| PROK | ProKidney Corp. | F- | 314,5M US$ | 1,04 US$ | — | 775K US$ | -13.326,7 % |
| LRMR | LARIMAR THERAPEUTICS, INC. | sin calificar | 312,7M US$ | 3,01 US$ | — | — | — |
| SCTX | SCRIBE THERAPEUTICS INC. | sin calificar | 310,2M US$ | 16,38 US$ | — | — | — |
| AUTL | AUTOLUS THERAPEUTICS PLC | C- | 309M US$ | 1,16 US$ | — | 137,4M US$ | -186,4 % |
| VERU | VERU INC. | sin calificar | 308,9M US$ | 2,11 US$ | — | — | — |
| GALT | GALECTIN THERAPEUTICS INC. | sin calificar | 308,6M US$ | 3,06 US$ | — | — | — |
| HELP | CYBIN INC. | sin calificar | 308M US$ | 8,85 US$ | — | — | — |
| MPLT | MapLight Therapeutics, Inc. | sin calificar | 307,7M US$ | 7,25 US$ | — | — | — |
| AGEN | AGENUS INC | D | 304,1M US$ | 6,72 US$ | 10,18 | 133,9M US$ | 23,0 % |
| IPSC | Century Therapeutics, Inc. | C- | 301,5M US$ | 1,66 US$ | — | 109,2M US$ | -90,5 % |
| PEPG | PEPGEN INC. | sin calificar | 301,3M US$ | 4,35 US$ | — | — | — |
| NAUT | NAUTILUS BIOTECHNOLOGY, INC. | sin calificar | 295,5M US$ | 2,32 US$ | — | — | — |
| ALLO | Allogene Therapeutics, Inc. | C- | 290,7M US$ | 0,84 US$ | — | 6,9M US$ | -2513,9 % |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | 288M US$ | 3,77 US$ | — | 0,00 US$ | — |
| TTRX | Turn Therapeutics Inc. | sin calificar | 285,9M US$ | 9,35 US$ | — | — | — |
| OCGN | OCUGEN, INC. | F | 280,9M US$ | 0,83 US$ | — | 4,8M US$ | -1367,6 % |
| CABA | CABALETTA BIO, INC. | sin calificar | 276,1M US$ | 1,28 US$ | — | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | 275,7M US$ | 3,46 US$ | — | 22,4M US$ | -269,7 % |
| YARW | YARROW BIOSCIENCE, INC. | D | 274,1M US$ | 17,99 US$ | — | 482K US$ | -3881,5 % |
| INO | INOVIO PHARMACEUTICALS, INC. | C- | 268,8M US$ | 1,44 US$ | — | 298,9K US$ | -23.798,9 % |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | 267,6M US$ | 2,97 US$ | — | 0,00 US$ | — |
| QTTB | Q32 Bio Inc. | B | 261,4M US$ | 8,74 US$ | 2,52 | 53,7M US$ | 60,0 % |
| FTH | Faeth Therapeutics, Inc. | sin calificar | 259,9M US$ | 10,06 US$ | — | — | — |
| PLX | PROTALIX BIOTHERAPEUTICS, INC. | A+ | 257,2M US$ | 3,05 US$ | 12,20 | 84,7M US$ | 24,3 % |
| RCKT | Rocket Pharmaceuticals, Inc. | D | 255,1M US$ | 2,29 US$ | — | 0,00 US$ | — |
| VOGX | Vogenx, Inc. | sin calificar | 252,1M US$ | 16,97 US$ | — | — | — |
| CUVL | CLINUVEL PHARMACEUTICALS LIMITED | C+ | 250,6M US$ | 4,97 US$ | 10,80 | 64,3M US$ | 36,0 % |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | 241,9M US$ | 4,00 US$ | — | 229,3M US$ | -119,9 % |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | 240,4M US$ | 8,34 US$ | — | 30,5M US$ | -285,9 % |
| IMRX | Immuneering Corporation | sin calificar | 240,1M US$ | 3,71 US$ | — | — | — |
| CAMP | CAMP4 Therapeutics Corporation | B- | 236,6M US$ | 3,77 US$ | — | 5,3M US$ | -2276,3 % |
| LXEO | Lexeo Therapeutics, Inc. | sin calificar | 235,5M US$ | 2,87 US$ | — | — | — |
| BCYC | Bicycle Therapeutics plc | C- | 234,4M US$ | 3,35 US$ | — | 83,5M US$ | -169,8 % |
| LCTX | Lineage Cell Therapeutics, Inc. | F | 229,4M US$ | 0,91 US$ | — | 10,8M US$ | 16,2 % |
| CTNM | Contineum Therapeutics, Inc. | sin calificar | 227,8M US$ | 9,86 US$ | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | sin calificar | 227,6M US$ | 14,11 US$ | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | sin calificar | 219,2M US$ | 14,94 US$ | — | — | — |
| ACIU | AC IMMUNE SA | D- | 216,2M US$ | 2,13 US$ | — | 4,5M US$ | -1903,0 % |
| IKT | INHIBIKASE THERAPEUTICS, INC. | F | 213,2M US$ | 1,52 US$ | — | 0,00 US$ | — |
| DTIL | PRECISION BIOSCIENCES INC | D- | 211,3M US$ | 7,57 US$ | — | 45M US$ | -85,6 % |
| KROS | KEROS THERAPEUTICS, INC. | F- | 202,7M US$ | 10,33 US$ | — | 40,8M US$ | -151,4 % |
| PALI | PALISADE BIO, INC. | F- | 199,9M US$ | 1,12 US$ | — | 500K US$ | -8739,2 % |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | 198,9M US$ | 5,08 US$ | — | 4M US$ | -4058,0 % |
| CGEN | COMPUGEN LTD | B+ | 198,6M US$ | 2,10 US$ | 5,53 | 75,9M US$ | 47,9 % |
| ARTV | Artiva Biotherapeutics, Inc. | F- | 198,2M US$ | 4,01 US$ | — | 0,00 US$ | — |
| ALPS | ALPS GROUP INC | sin calificar | 198M US$ | 1,19 US$ | — | — | — |
| LIMN | LIMINATUS PHARMA, INC. | sin calificar | 196,1M US$ | 2,92 US$ | — | — | — |
| RNAC | Cartesian Therapeutics, Inc. | F | 193,7M US$ | 6,35 US$ | — | 1M US$ | -12.435,2 % |
| PYXS | Pyxis Oncology, Inc. | D- | 189M US$ | 1,58 US$ | — | 13,9M US$ | -625,7 % |
| KRRO | Korro Bio, Inc. | D- | 186,3M US$ | 13,57 US$ | — | 1,3M US$ | -8214,5 % |
| ACOG | Alpha Cognition Inc. | D- | 184,4M US$ | 8,37 US$ | — | 20,2M US$ | -144,6 % |
| OVID | Ovid Therapeutics Inc. | D- | 181M US$ | 2,55 US$ | — | 1,5M US$ | -2971,3 % |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | 180,6M US$ | 3,06 US$ | — | 0,00 US$ | — |
| ELDN | ELEDON PHARMACEUTICALS, INC. | sin calificar | 178,2M US$ | 2,11 US$ | — | — | — |
| ANTX | AN2 Therapeutics, Inc. | sin calificar | 173,4M US$ | 4,57 US$ | — | — | — |
| IVVD | INVIVYD, INC. | D- | 171,8M US$ | 0,58 US$ | — | 58,4M US$ | -183,9 % |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | sin calificar | 171,3M US$ | 2,14 US$ | — | — | — |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | 167,1M US$ | 1,70 US$ | — | 0,00 US$ | — |
| MDWD | MEDIWOUND LTD. | F- | 165,3M US$ | 12,88 US$ | — | 10M US$ | -235,0 % |
| STRO | SUTRO BIOPHARMA, INC. | D | 163,2M US$ | 9,83 US$ | — | 45,1M US$ | -344,2 % |
| GTBP | GT Biopharma, Inc. | sin calificar | 162,8M US$ | 3,61 US$ | 9,75 | — | — |
| RNA | Atrium Therapeutics, Inc. | sin calificar | 162M US$ | 7,51 US$ | — | — | — |
| ENGN | enGene Therapeutics Inc. | sin calificar | 161,5M US$ | 2,41 US$ | — | — | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | 160,9M US$ | 3,70 US$ | — | 2M US$ | 7244,3 % |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | sin calificar | 159,2M US$ | 23,15 US$ | — | — | — |
| SLGL | Sol-Gel Technologies Ltd. | D | 156M US$ | 56,01 US$ | — | 1,4M US$ | -426,7 % |
| TARA | Protara Therapeutics, Inc. | sin calificar | 155,5M US$ | 2,53 US$ | — | — | — |
| FATE | FATE THERAPEUTICS INC | F- | 155M US$ | 1,28 US$ | — | 4,8M US$ | -2619,6 % |
| HUMA | Humacyte, Inc. | C- | 154M US$ | 0,55 US$ | — | 2,4M US$ | -3955,1 % |
| UPB | UPSTREAM BIO, INC. | F- | 151,3M US$ | 2,76 US$ | — | 2,9M US$ | -5712,3 % |
| SION | SIONNA THERAPEUTICS, INC. | sin calificar | 150,6M US$ | 3,33 US$ | — | — | — |
| NGEN | NERVGEN PHARMA CORP. | sin calificar | 149,7M US$ | 1,88 US$ | — | — | — |
| PRQR | ProQR Therapeutics N.V. | C- | 147,5M US$ | 1,40 US$ | — | 22,8M US$ | -204,4 % |
| ALXO | ALX ONCOLOGY HOLDINGS INC | sin calificar | 143,1M US$ | 1,04 US$ | — | — | — |
| ARMP | ARMATA PHARMACEUTICALS, INC. | sin calificar | 142,8M US$ | 3,84 US$ | — | — | — |
| MGNX | MACROGENICS, INC. | D- | 141,9M US$ | 2,22 US$ | — | 154,9M US$ | -33,2 % |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | 141,7M US$ | 4,91 US$ | — | 40K US$ | -107.587,6 % |
| CMPX | COMPASS THERAPEUTICS, INC. | F | 139,2M US$ | 0,77 US$ | — | 0,00 US$ | — |
| ABEO | ABEONA THERAPEUTICS INC. | C- | 137,7M US$ | 2,41 US$ | — | 39M US$ | -160,3 % |
| MENS | Jyong Biotech Ltd. | sin calificar | 132,3M US$ | 1,74 US$ | — | — | — |
| IPHA | Innate Pharma SA | F- | 130,3M US$ | 1,39 US$ | — | 10,1M US$ | -546,1 % |
| LENZ | LENZ THERAPEUTICS, INC. | F- | 129,8M US$ | 4,13 US$ | — | 12,4M US$ | -1135,0 % |
| CDXS | Codexis, Inc. | B- | 124,4M US$ | 1,14 US$ | — | 88,3M US$ | -21,8 % |
| SPRB | Spruce Biosciences, Inc. | F | 123,9M US$ | 43,12 US$ | — | 0,00 US$ | — |
| FHTX | Foghorn Therapeutics Inc. | B | 123,8M US$ | 2,07 US$ | 29,50 | 112,1M US$ | 8,4 % |
| CLLS | Cellectis S.A. | F- | 119,8M US$ | 1,20 US$ | — | 25,2M US$ | -506,1 % |
| ZURA | Zura Bio Limited | sin calificar | 119,4M US$ | 1,24 US$ | — | — | — |
| CUE | Cue Biopharma, Inc. | D- | 117,4M US$ | 16,16 US$ | — | 37,7M US$ | -435,8 % |
| NERV | Minerva Neurosciences, Inc. | sin calificar | 115,1M US$ | 2,31 US$ | — | — | — |
| PYPD | PolyPid Ltd | sin calificar | 114,5M US$ | 6,29 US$ | — | — | — |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | 110,1M US$ | 4,44 US$ | — | 194K US$ | -3985,6 % |
| IBIO | iBio, Inc. | C- | 110M US$ | 0,73 US$ | — | 1,1M US$ | -3244,2 % |
| VYGR | Voyager Therapeutics, Inc. | F- | 107,3M US$ | 1,73 US$ | — | 25,1M US$ | -416,3 % |
| OKUR | ONKURE THERAPEUTICS, INC. | sin calificar | 106,3M US$ | 2,63 US$ | — | — | — |
| EQ | Equillium, Inc. | sin calificar | 106,2M US$ | 1,29 US$ | — | — | — |
| MSLE | Satellos Bioscience Inc. | sin calificar | 102,5M US$ | 6,63 US$ | — | — | — |
| ADAG | Adagene Inc. | C- | 101M US$ | 1,71 US$ | — | 7,7M US$ | -229,6 % |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | 100,6M US$ | 0,41 US$ | — | -1,2M US$ | 5253,5 % |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | sin calificar | 98,9M US$ | 3,55 US$ | — | — | — |
| ICCC | ImmuCell Corporation | A | 97,6M US$ | 10,74 US$ | 56,53 | 33,2M US$ | 5,7 % |
| NBP | NovaBridge Biosciences | sin calificar | 96,3M US$ | 0,83 US$ | — | — | — |
| PMVP | PMV PHARMACEUTICALS, INC. | sin calificar | 95,6M US$ | 1,27 US$ | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | 92,1M US$ | 1,40 US$ | — | 0,00 US$ | — |
| ANIX | ANIXA BIOSCIENCES, INC. | sin calificar | 91,6M US$ | 2,64 US$ | — | — | — |
| VANI | Vivani Medical, Inc. | F | 91,6M US$ | 1,02 US$ | — | 0,00 US$ | — |
| PLYX | Polaryx Therapeutics, Inc. | sin calificar | 91,5M US$ | 1,84 US$ | — | — | — |
| SEER | SEER, INC. | F- | 87,6M US$ | 1,57 US$ | — | 14,1M US$ | -450,9 % |
| AVXL | ANAVEX LIFE SCIENCES CORP. | sin calificar | 86,5M US$ | 0,93 US$ | — | — | — |
| CBUS | Cibus, Inc. | C- | 86,2M US$ | 1,13 US$ | — | 4,5M US$ | -2131,4 % |
| NKTX | Nkarta, Inc. | D | 85,3M US$ | 1,19 US$ | — | 0,00 US$ | — |
| GNLX | GENELUX CORPORATION | F- | 85,1M US$ | 1,88 US$ | — | 8K US$ | -444.950,0 % |
| RLYB | RALLYBIO CORPORATION | A | 84,9M US$ | 15,76 US$ | — | 434K US$ | 6177,4 % |
| IFRX | InflaRx N.V. | F- | 84,6M US$ | 1,17 US$ | — | 32,8K US$ | -155.582,1 % |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | F | 83,9M US$ | 1,46 US$ | — | 0,00 US$ | — |
| LONA | LeonaBio, Inc. | sin calificar | 82,3M US$ | 3,47 US$ | — | — | — |
| CHRS | Coherus Oncology, Inc. | C | 80,7M US$ | 0,52 US$ | — | 53,6M US$ | -253,4 % |
| NMRA | NEUMORA THERAPEUTICS, INC. | sin calificar | 80,6M US$ | 0,43 US$ | — | — | — |
| ATRA | Atara Biotherapeutics, Inc. | F | 80,5M US$ | 7,90 US$ | — | 4M US$ | -368,6 % |
| TNYA | TENAYA THERAPEUTICS, INC. | sin calificar | 79,1M US$ | 0,35 US$ | — | — | — |
| NRXS | NEURAXIS, INC. | D- | 78M US$ | 5,50 US$ | — | 6,5M US$ | -185,2 % |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | 73,8M US$ | 0,53 US$ | — | 6,6M US$ | -493,0 % |
| TENX | TENAX THERAPEUTICS, INC. | F | 73,8M US$ | 1,62 US$ | — | 0,00 US$ | — |
| COYA | Coya Therapeutics, Inc. | F- | 73,2M US$ | 3,12 US$ | — | 4,7M US$ | -643,5 % |
| NTRB | NUTRIBAND INC. | F- | 72,3M US$ | 5,95 US$ | — | 1,6M US$ | -430,4 % |
| PMCB | PHARMACYTE BIOTECH, INC. | D | 71,7M US$ | 6,68 US$ | — | 0,00 US$ | — |
| MNOV | MEDICINOVA, INC. | D- | 71,2M US$ | 1,39 US$ | — | 935,7K US$ | -1127,0 % |
| OKYO | OKYO Pharma Limited | sin calificar | 69,8M US$ | 1,33 US$ | — | — | — |
| FBIO | Fortress Biotech, Inc. | B | 69,7M US$ | 1,88 US$ | — | 70M US$ | 143,0 % |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | sin calificar | 69,7M US$ | 3,38 US$ | — | — | — |
| JAGX | Jaguar Health, Inc. | C | 69,4M US$ | 0,40 US$ | — | 27,8M US$ | -132,2 % |
| TLSA | Tiziana Life Sciences Ltd | sin calificar | 68,1M US$ | 0,57 US$ | — | — | — |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | 67,9M US$ | 4,88 US$ | — | 60,7M US$ | -1,8 % |
| GOSS | GOSSAMER BIO, INC. | B | 67M US$ | 10,95 US$ | — | 78,4M US$ | -159,5 % |
| CING | Cingulate Inc. | sin calificar | 64,9M US$ | 4,34 US$ | — | — | — |
| MIST | Milestone Pharmaceuticals Inc. | sin calificar | 64,8M US$ | 0,52 US$ | — | — | — |
| CGTX | Cognition Therapeutics, Inc. | sin calificar | 63,8M US$ | 0,67 US$ | — | — | — |
| ACRV | Acrivon Therapeutics, Inc. | sin calificar | 62,1M US$ | 1,45 US$ | — | — | — |
| MAIA | MAIA BIOTECHNOLOGY, INC. | sin calificar | 61,8M US$ | 1,00 US$ | — | — | — |
| ETRA | Electra Therapeutics, Inc. | sin calificar | 61,7M US$ | 8,96 US$ | — | — | — |
| VRCA | Verrica Pharmaceuticals Inc. | D- | 61,5M US$ | 3,58 US$ | — | 22,9M US$ | -189,2 % |
| CNXU | CONEXEU SCIENCES INC. | sin calificar | 61,5M US$ | 2,18 US$ | — | — | — |
| XBIT | XBIOTECH INC. | sin calificar | 59,5M US$ | 1,95 US$ | — | — | — |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | D- | 59,3M US$ | 0,31 US$ | — | 148,2M US$ | -14,5 % |
| BOLD | BOUNDLESS BIO, INC. | sin calificar | 59M US$ | 2,50 US$ | — | — | — |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | 58,5M US$ | 3,01 US$ | — | 43M US$ | -420,4 % |
| CLGN | CollPlant Biotechnologies Ltd | D- | 58,4M US$ | 4,56 US$ | — | 318K US$ | -4130,2 % |
| SPRO | SPERO THERAPEUTICS, INC. | F- | 57,8M US$ | 0,99 US$ | — | 41,6M US$ | -71,0 % |
| XLO | Xilio Therapeutics, Inc. | D- | 57,6M US$ | 8,16 US$ | — | 55M US$ | -20,9 % |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | 56,6M US$ | 0,73 US$ | — | 559K US$ | -6735,2 % |
| ANVS | Annovis Bio, Inc. | F | 56,4M US$ | 0,91 US$ | — | 0,00 US$ | — |
| CLNN | Clene Inc. | C | 56,3M US$ | 3,91 US$ | — | 238K US$ | -11.271,4 % |
| AZR | Azora Therapeutics, Inc. (DE) | sin calificar | 56,1M US$ | 3,93 US$ | — | — | — |
| NRSN | NeuroSense Therapeutics Ltd. | sin calificar | 53,1M US$ | 1,63 US$ | — | — | — |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | 51,9M US$ | 12,87 US$ | 1,53 | 0,00 US$ | — |
| ATNM | Actinium Pharmaceuticals, Inc. | D+ | 51,6M US$ | 1,64 US$ | 4,56 | 90K US$ | 12.564,4 % |
| RNXT | RENOVORX, INC. | D- | 50,4M US$ | 1,05 US$ | — | 2,8M US$ | -469,0 % |
| ONCY | ONCOLYTICS BIOTECH INC. | sin calificar | 50,2M US$ | 0,37 US$ | — | — | — |
| MREO | MEREO BIOPHARMA GROUP PLC | C | 49M US$ | 0,31 US$ | — | 500K US$ | -5387,6 % |
| PDSB | PDS Biotechnology Corporation | sin calificar | 48,5M US$ | 0,87 US$ | — | — | — |
| INKT | MiNK Therapeutics, Inc. | sin calificar | 48,3M US$ | 9,41 US$ | — | — | — |
| HYFT | MindWalk Holdings Corp. | C- | 48,1M US$ | 1,03 US$ | — | 20,1M US$ | -43,6 % |
| HOWL | WEREWOLF THERAPEUTICS, INC. | sin calificar | 47,6M US$ | 0,98 US$ | — | — | — |
| RNTX | Rein Therapeutics, Inc. | F | 46,9M US$ | 0,54 US$ | — | 0,00 US$ | — |
| GANX | GAIN THERAPEUTICS, INC | sin calificar | 46,3M US$ | 1,04 US$ | — | — | — |
| DWTX | Dogwood Therapeutics, Inc. | sin calificar | 44,3M US$ | 1,16 US$ | — | — | — |
| IBO | Impact BioMedical, INC. | A | 44,2M US$ | 5,11 US$ | — | 38K US$ | 4247,4 % |
| PLRX | PLIANT THERAPEUTICS, INC. | D | 43,2M US$ | 0,70 US$ | — | 0,00 US$ | — |
| IMA | ImageneBio, Inc. | C- | 43,1M US$ | 3,46 US$ | — | 800K US$ | -5415,6 % |
| CNTB | Connect Biopharma Holdings Limited | C- | 42,6M US$ | 0,68 US$ | — | 3M US$ | -2336,3 % |
| BMEA | Biomea Fusion, Inc. | sin calificar | 42,3M US$ | 0,58 US$ | — | — | — |
| ELTX | Elicio Therapeutics, Inc. | sin calificar | 42,2M US$ | 1,49 US$ | — | — | — |
| TIL | Instil Bio, Inc. | C- | 41M US$ | 6,05 US$ | — | 9M US$ | -337,7 % |
| HYPD | HYPERION DEFI, INC. | B+ | 40,1M US$ | 2,59 US$ | — | 1,9M US$ | 2075,4 % |
| SER | Serina Therapeutics, Inc. | D | 39,9M US$ | 1,50 US$ | — | 260K US$ | -9421,5 % |
| ALDX | ALDEYRA THERAPEUTICS, INC. | sin calificar | 39,3M US$ | 0,65 US$ | — | — | — |
| CRBU | Caribou Biosciences, Inc. | F- | 39,2M US$ | 0,36 US$ | — | 9,4M US$ | -1085,0 % |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | 38,5M US$ | 1,51 US$ | — | 357,9K US$ | -3089,6 % |
| TVGN | Tevogen Inc. | sin calificar | 38,4M US$ | 5,90 US$ | — | — | — |
| GRCE | Grace Therapeutics, Inc. | sin calificar | 38M US$ | 1,81 US$ | — | — | — |
| KLRS | KALARIS THERAPEUTICS, INC. | sin calificar | 37,5M US$ | 1,58 US$ | — | — | — |
| EXOZ | EXOZYMES INC. | sin calificar | 36,8M US$ | 3,90 US$ | — | — | — |
| TELO | Telomir Pharmaceuticals, Inc. | sin calificar | 36,2M US$ | 0,49 US$ | — | — | — |
| OSTX | OS THERAPIES INCORPORATED | sin calificar | 34,4M US$ | 0,75 US$ | — | — | — |
| INMB | INMUNE BIO INC. | D- | 32,5M US$ | 1,05 US$ | — | 50K US$ | -33.332,0 % |
| NNVC | NANOVIRICIDES, INC. | F | 31,5M US$ | 1,24 US$ | — | 0,00 US$ | — |
| PMN | PROMIS NEUROSCIENCES INC. | sin calificar | 29,6M US$ | 3,29 US$ | — | — | — |
| BCTX | BRIACELL THERAPEUTICS CORP. | sin calificar | 29,3M US$ | 3,35 US$ | — | — | — |
| AARD | AARDVARK THERAPEUTICS, INC. | F | 29,1M US$ | 1,33 US$ | — | 0,00 US$ | — |
| PTHS | Pelthos Therapeutics Inc. | D- | 28,6M US$ | 7,29 US$ | — | 51,3M US$ | -152,2 % |
| NXTC | NextCure, Inc. | sin calificar | 28,6M US$ | 6,24 US$ | — | — | — |
| IMMP | Immutep Limited | D- | 26,9M US$ | 3,65 US$ | — | 7,3M US$ | -594,6 % |
| GRDX | GridAI Technologies Corp. | F- | 26,7M US$ | 3,74 US$ | — | 36,3K US$ | -56.864,0 % |
| MGX | Metagenomi Therapeutics, Inc. | F- | 26,4M US$ | 0,70 US$ | — | 22,3M US$ | -421,8 % |
| ALGS | Aligos Therapeutics, Inc. | F- | 26,3M US$ | 2,11 US$ | — | 5,8M US$ | -1137,2 % |
| ACET | Adicet Bio, Inc. | sin calificar | 25,8M US$ | 2,76 US$ | — | — | — |
| CRVO | CervoMed Inc. | F- | 25,3M US$ | 1,68 US$ | — | 8,7K US$ | -326.822,5 % |
| BYSI | BeyondSpring Inc. | D | 25,2M US$ | 0,61 US$ | — | 0,00 US$ | — |
| LITS | Lite Strategy, Inc. | D | 25,1M US$ | 0,84 US$ | — | 0,00 US$ | — |
| ABVC | ABVC BioPharma, Inc. | D- | 24,5M US$ | 0,91 US$ | — | 296K US$ | -1322,6 % |
| APRE | Aprea Therapeutics, Inc. | sin calificar | 23,9M US$ | 0,44 US$ | — | — | — |
| ENLV | Enlivex Ltd. | sin calificar | 22,8M US$ | 1,18 US$ | 0,01 | — | — |
| EVAX | Evaxion A/S | B- | 22,8M US$ | 2,74 US$ | — | 7,5M US$ | -102,4 % |
| CVM | CEL-SCI CORPORATION | sin calificar | 22,3M US$ | 1,27 US$ | — | — | — |
| FLNA | Filana Therapeutics, Inc. | sin calificar | 21,4M US$ | 0,43 US$ | — | — | — |
| ATHE | ALTERITY THERAPEUTICS LTD | sin calificar | 21,2M US$ | 1,99 US$ | — | — | — |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | sin calificar | 20,9M US$ | 0,48 US$ | — | — | — |
| IGC | IGC PHARMA, INC. | C- | 20,7M US$ | 0,18 US$ | — | 1,3M US$ | -560,3 % |
| CNSP | CNS Pharmaceuticals, Inc. | sin calificar | 20,4M US$ | 2,98 US$ | — | — | — |
| CELU | Celularity Inc. | D | 20,2M US$ | 0,62 US$ | — | 18,7M US$ | -245,7 % |
| BSEM | BioStem Technologies, Inc. | sin calificar | 20,1M US$ | 1,05 US$ | — | 47,5M US$ | -13,9 % |
| APLM | Apollomics Inc. | B | 19,9M US$ | 18,01 US$ | — | 8,5M US$ | -128,7 % |
| ATOS | ATOSSA THERAPEUTICS, INC. | sin calificar | 19,4M US$ | 1,95 US$ | — | — | — |
| NRXP | NRX Pharmaceuticals, Inc. | B | 19,4M US$ | 2,19 US$ | — | 3,4M US$ | -691,8 % |
| COCP | COCRYSTAL PHARMA, INC. | sin calificar | 19,4M US$ | 1,01 US$ | — | — | — |
| LPCN | LIPOCINE INC. | D- | 19M US$ | 1,72 US$ | — | 3,7M US$ | -249,2 % |
| KTTA | PASITHEA THERAPEUTICS CORP. | sin calificar | 19M US$ | 0,52 US$ | — | — | — |
| EDSA | EDESA BIOTECH, INC. | sin calificar | 18,7M US$ | 1,94 US$ | — | — | — |
| PLUR | Pluri Inc. | B | 17,3M US$ | 1,20 US$ | — | 1,5M US$ | -1943,9 % |
| CNTX | CONTEXT THERAPEUTICS INC. | sin calificar | 17,1M US$ | 0,19 US$ | — | — | — |
| BOLT | Bolt Biotherapeutics, Inc. | F- | 15,9M US$ | 6,09 US$ | — | 2,5M US$ | -1034,4 % |
| TVRD | TVARDI THERAPEUTICS, INC. | F- | 15,8M US$ | 1,18 US$ | — | 7,6M US$ | -352,1 % |
| ATYR | ATYR PHARMA, INC. | F- | 15,6M US$ | 6,11 US$ | — | 190K US$ | -28.065,3 % |
| ALLR | Allarity Therapeutics, Inc. | C- | 15,5M US$ | 0,97 US$ | — | 350K US$ | -4493,7 % |
| ABOS | Acumen Pharmaceuticals, Inc. | sin calificar | 15,4M US$ | 0,21 US$ | — | — | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | 15M US$ | 0,90 US$ | — | 3,9M US$ | -220,5 % |
| CTXR | Citius Pharmaceuticals, Inc. | sin calificar | 14,7M US$ | 0,54 US$ | — | — | — |
| KYNB | KYNTRA BIO, INC. | F | 14,6M US$ | 3,60 US$ | — | 4,6M US$ | 3967,8 % |
| MCRB | Seres Therapeutics, Inc. | D- | 14,2M US$ | 1,39 US$ | — | 2,1M US$ | -2209,6 % |
| LSTA | LISATA THERAPEUTICS, INC. | F- | 13,5M US$ | 1,25 US$ | — | 100K US$ | -17.159,0 % |
| PASG | Passage BIO, Inc. | sin calificar | 13,4M US$ | 4,16 US$ | — | — | — |
| DYAI | DYADIC INTERNATIONAL, INC. | D- | 13,3M US$ | 0,33 US$ | — | 3,1M US$ | -226,9 % |
| BCDA | BioCardia, Inc. | F | 13M US$ | 0,86 US$ | — | 0,00 US$ | — |
| ONCO | Onconetix, Inc. | F- | 12,6M US$ | 3,20 US$ | — | 645,8K US$ | -1578,8 % |
| NIKI | Niki BioSolutions, Inc. | sin calificar | 12,5M US$ | 1,71 US$ | — | — | — |
| NCEL | NewcelX Ltd. | sin calificar | 12,5M US$ | 2,60 US$ | — | — | — |
| BIVI | BIOVIE INC. | sin calificar | 12,2M US$ | 1,14 US$ | — | — | — |
| GUTS | Fractyl Health, Inc. | F- | 12M US$ | 0,91 US$ | — | 0,00 US$ | — |
| CLRB | Cellectar Biosciences, Inc. | sin calificar | 11,4M US$ | 1,14 US$ | — | — | — |
| PTN | PALATIN TECHNOLOGIES, INC. | B- | 11,2M US$ | 6,29 US$ | — | 13,2M US$ | -63,6 % |
| HIND | VYOME HOLDINGS, INC. | D- | 11,2M US$ | 1,59 US$ | — | 153,1K US$ | -2455,6 % |
| CMMB | SNOWDRIFT PARENT CORPORATION | sin calificar | 11,1M US$ | 1,54 US$ | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | 10,9M US$ | 0,16 US$ | — | 5,2M US$ | -2219,2 % |
| KZIA | Kazia Therapeutics Limited. | F | 10,7M US$ | 6,62 US$ | 5,83 | 29,5K US$ | -54.287,3 % |
| INTS | INTENSITY THERAPEUTICS, INC. | sin calificar | 10M US$ | 3,03 US$ | — | — | — |
| DARE | Dare Bioscience, Inc. | C- | 9,9M US$ | 0,65 US$ | — | 1,4M US$ | -804,4 % |
| GDTC | CytoMed Therapeutics Limited | D- | 9,6M US$ | 0,81 US$ | — | 253,7K US$ | -1227,1 % |
| ICU | SeaStar Medical Holding Corp | D- | 9,3M US$ | 0,82 US$ | — | 2,2M US$ | -678,2 % |
| CNSY | CERENOME, INC. | F- | 9,2M US$ | 0,94 US$ | — | 3,5M US$ | -859,5 % |
| INAB | IN8BIO, INC. | sin calificar | 9M US$ | 0,84 US$ | — | — | — |
| RADX | Radiopharm Theranostics Limited | F- | 8,9M US$ | 0,75 US$ | — | 3,6M US$ | -1055,3 % |
| MTVA | METAVIA INC. | sin calificar | 8,7M US$ | 1,29 US$ | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | 8,7M US$ | 8,16 US$ | — | 0,00 US$ | — |
| CALC | CalciMedica, Inc. | sin calificar | 8,3M US$ | 1,21 US$ | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | 8,3M US$ | 0,18 US$ | — | 2,4M US$ | -2474,5 % |
| ENSC | ENSYSCE BIOSCIENCES, INC. | F- | 8,1M US$ | 0,42 US$ | — | 6,2M US$ | -1470,4 % |
| AEON | AEON Biopharma, Inc. | sin calificar | 7,8M US$ | 0,16 US$ | — | — | — |
| CURX | Curanex Pharmaceuticals Inc | sin calificar | 7,5M US$ | 4,79 US$ | — | — | — |
| SNGX | SOLIGENIX, INC. | sin calificar | 7,5M US$ | 0,32 US$ | — | — | — |
| TPST | Tempest Therapeutics, Inc. | sin calificar | 7,4M US$ | 0,37 US$ | — | — | — |
| ACTU | Actuate Therapeutics, Inc. | sin calificar | 7M US$ | 0,29 US$ | — | — | — |
| IMRN | IMMURON LIMITED | D- | 6,9M US$ | 0,86 US$ | — | 5,1M US$ | -71,6 % |
| ENVB | ENVERIC BIOSCIENCES, INC. | sin calificar | 6,8M US$ | 1,51 US$ | — | — | — |
| TOVX | THERIVA BIOLOGICS, INC. | sin calificar | 6,6M US$ | 0,14 US$ | — | — | — |
| XCUR | EXICURE, INC. | F | 6,5M US$ | 1,00 US$ | — | 0,00 US$ | — |
| FBLG | FibroBiologics, Inc. | sin calificar | 6,4M US$ | 0,97 US$ | — | — | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | B- | 6,2M US$ | 2,09 US$ | — | 15,2K US$ | -42.721,9 % |
| ALZN | ALZAMEND NEURO, INC. | sin calificar | 6M US$ | 1,25 US$ | — | — | — |
| AIM | AIM IMMUNOTECH INC. | F | 5,8M US$ | 0,14 US$ | — | 91K US$ | -15.526,4 % |
| ACXP | Acurx Pharmaceuticals, Inc. | sin calificar | 5,8M US$ | 0,95 US$ | — | — | — |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | sin calificar | 5,6M US$ | 0,88 US$ | — | — | — |
| BLRX | BioLineRx Ltd | C- | 5,6M US$ | 1,28 US$ | — | 1,4M US$ | -145,5 % |
| LTRN | LANTERN PHARMA INC. | sin calificar | 5,5M US$ | 0,43 US$ | — | — | — |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | 5,5M US$ | 1,24 US$ | — | 0,00 US$ | — |
| CVKD | Cadrenal Therapeutics, Inc. | sin calificar | 5,4M US$ | 1,51 US$ | — | — | — |
| PCSA | Processa Pharmaceuticals, Inc. | sin calificar | 5,3M US$ | 1,90 US$ | — | — | — |
| CMND | Clearmind Medicine Inc. | sin calificar | 5,2M US$ | 4,46 US$ | — | — | — |
| SKYE | Skye Bioscience, Inc. | sin calificar | 5M US$ | 1,14 US$ | — | — | — |
| ADXN | Addex Therapeutics Ltd | D- | 4,9M US$ | 3,98 US$ | — | 36,4K US$ | -22.448,4 % |
| PULM | Pulmatrix, Inc. | C- | 4,6M US$ | 1,26 US$ | — | 7,8M US$ | -51,4 % |
| SNTI | Senti Biosciences Holdings, Inc. | F- | 4,4M US$ | 0,14 US$ | — | 55K US$ | -90.116,4 % |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | 4,2M US$ | 1,77 US$ | — | 451K US$ | -1545,2 % |
| TCRT | Alaunos Therapeutics, Inc. | D- | 4,1M US$ | 1,63 US$ | — | 3K US$ | -133.666,7 % |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | D- | 4M US$ | 0,53 US$ | — | 3K US$ | -249.160,1 % |
| XBIO | XENETIC BIOSCIENCES, INC. | F- | 4M US$ | 1,71 US$ | — | 3M US$ | -123,7 % |
| TRAW | Traws Pharma, Inc. | D- | 4M US$ | 0,26 US$ | — | 2,8M US$ | -773,0 % |
| GRI | GRI Bio, Inc. | sin calificar | 4M US$ | 1,82 US$ | — | — | — |
| SILO | SILO PHARMA, INC. | D- | 3,9M US$ | 1,83 US$ | — | 36,1K US$ | -10.319,0 % |
| AZTR | Azitra, Inc. | F- | 3,8M US$ | 0,62 US$ | — | 0,00 US$ | — |
| IMNN | Imunon, Inc. | sin calificar | 3,7M US$ | 0,58 US$ | — | — | — |
| PHIO | Phio Pharmaceuticals Corp | sin calificar | 3,7M US$ | 0,77 US$ | — | — | — |
| AGMB | AgomAb Therapeutics NV | sin calificar | 3,4M US$ | 6,27 US$ | — | — | — |
| MBIO | MUSTANG BIO, INC. | sin calificar | 3,4M US$ | 0,45 US$ | — | — | — |
| ERNA | Ernexa Therapeutics Inc. | sin calificar | 3,1M US$ | 1,85 US$ | — | — | — |
| EVGN | EVOGENE LTD. | F | 3,1M US$ | 0,36 US$ | — | 1,3M US$ | -551,3 % |
| REVB | REVELATION BIOSCIENCES, INC. | sin calificar | 2,9M US$ | 4,28 US$ | — | — | — |
| DRMA | DERMATA THERAPEUTICS, INC. | sin calificar | 2,9M US$ | 0,59 US$ | — | — | — |
| GNPX | Genprex, Inc. | sin calificar | 2,8M US$ | 2,09 US$ | — | — | — |
| VIVS | VivoSim Labs, Inc. | C | 2,5M US$ | 0,13 US$ | — | 135K US$ | -7605,9 % |
| VRAX | Virax Biolabs Group Ltd | C- | 2,3M US$ | 0,63 US$ | — | 6,3K US$ | -95.739,2 % |
| CLDI | Calidi Biotherapeutics, Inc. | sin calificar | 2,2M US$ | 0,63 US$ | — | — | — |
| KAPA | KAIROS PHARMA, LTD. | sin calificar | 2,2M US$ | 0,46 US$ | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | sin calificar | 2M US$ | 1,95 US$ | — | — | — |
| ARTL | ARTELO BIOSCIENCES, INC. | sin calificar | 2M US$ | 2,18 US$ | — | — | — |
| ELAB | PMGC HOLDINGS INC. | D- | 1,9M US$ | 1,63 US$ | — | 4,8M US$ | -275,7 % |
| CRIS | CURIS INC | F- | 1,9M US$ | 0,44 US$ | — | 4,3M US$ | -499,4 % |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | 1,8M US$ | 0,50 US$ | — | 1,1M US$ | -729,9 % |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | 1,8M US$ | 2,28 US$ | — | 21,8K US$ | -42.206,9 % |
| PBM | PSYENCE BIOMEDICAL LTD | sin calificar | 1,7M US$ | 3,16 US$ | — | — | — |
| HCWB | HCW Biologics Inc. | B- | 1,6M US$ | 0,86 US$ | — | 6,7M US$ | -83,8 % |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | 1,4M US$ | 0,41 US$ | — | 3,1M US$ | -270,9 % |
| BDRX | Biodexa Pharmaceuticals PLC | sin calificar | 1,3M US$ | 2,39 US$ | — | — | — |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | sin calificar | 1,3M US$ | 1,32 US$ | — | — | — |
| CANF | Can-Fite BioPharma Ltd. | F- | 1,2M US$ | 1,46 US$ | — | 405K US$ | -2426,7 % |
| BBLG | Bone Biologics Corporation | sin calificar | 1,1M US$ | 0,33 US$ | — | — | — |
| APVO | Aptevo Therapeutics Inc. | sin calificar | 1,1M US$ | 0,59 US$ | — | — | — |
| GOVX | GEOVAX LABS, INC. | D | 928,3K US$ | 1,71 US$ | — | 0,00 US$ | — |
| OGEN | ORAGENICS, INC. | sin calificar | 906,9K US$ | 0,20 US$ | — | — | — |
| DCOY | Decoy Therapeutics Inc. | sin calificar | 811,6K US$ | 0,96 US$ | — | — | — |
| HLSQ | BiomX Inc. | sin calificar | 739,4K US$ | 0,07 US$ | — | — | — |
| QNRX | Quoin Pharmaceuticals, Ltd. | sin calificar | 669,6K US$ | 3,81 US$ | — | — | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | sin calificar | 658,5K US$ | 0,28 US$ | — | — | — |
| EDVA | Endovia Health Sciences, Inc. | D | 542,2K US$ | 0,18 US$ | — | 32,1K US$ | -53.856,5 % |
| PLRZ | Polyrizon Ltd. | sin calificar | 508,2K US$ | 11,21 US$ | 2,29 | — | — |
| VBIO | Valion Bio, Inc. | F- | 461,2K US$ | 0,52 US$ | — | 482K US$ | -3890,0 % |
| SRZN | Surrozen, Inc./DE | D | 370,9K US$ | 31,50 US$ | — | 10,5M US$ | -3706,4 % |
| SLXN | SILEXION THERAPEUTICS CORP | sin calificar | 363,4K US$ | 1,97 US$ | — | — | — |
| LGVN | LONGEVERON INC. | F- | 339,1K US$ | 2,45 US$ | — | 1,2M US$ | -1921,7 % |
| CDT | CDT EQUITY INC. | sin calificar | 307,4K US$ | 0,39 US$ | — | — | — |
| SPRC | SCISPARC LTD. | F- | 132,6K US$ | 0,36 US$ | — | 679K US$ | -1793,7 % |
| NEUP | Neuphoria Therapeutics Inc. | F- | 76,2K US$ | 2,54 US$ | — | 1,2M US$ | -1145,7 % |
| EYPT | EyePoint, Inc. | F- | 27,6K US$ | 0,31 US$ | — | 2,6M US$ | -13.281,2 % |
| KALA | KALA BIO, INC. | F | 10,1K US$ | 0,14 US$ | — | 0,00 US$ | — |
| KPTI | Karyopharm Therapeutics Inc. | C | 503,52 US$ | 0,02 US$ | — | 146,6M US$ | -153,3 % |
| PPBT | PURPLE BIOTECH LTD. | sin calificar | 370,84 US$ | 1,55 US$ | — | — | — |
| QNTM | Quantum BioPharma Ltd. | sin calificar | 19,50 US$ | 1,63 US$ | — | — | — |
| APGE | Apogee Therapeutics, Inc. | sin calificar | — | 135,07 US$ | — | — | — |
| ATAI | AtaiBeckley Inc. | sin calificar | — | 7,35 US$ | — | 4,1M US$ | -16.142,0 % |
| BCAB | BIOATLA, INC. | sin calificar | — | 1,74 US$ | — | — | — |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | 0,74 US$ | — | 0,00 US$ | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | 84,95 US$ | — | 42,2M US$ | -1189,9 % |
| FBRX | FORTE BIOSCIENCES, INC. | sin calificar | — | 76,99 US$ | — | — | — |
| LNAI | LUNAI BIOWORKS INC. | B | — | 0,16 US$ | — | 52K US$ | -6852,0 % |
| MLEC | MOOLEC SCIENCE SA | B | — | 0,85 US$ | — | 333,6M US$ | -52,9 % |
| MOLN | MOLECULAR PARTNERS AG | F | — | 3,22 US$ | — | 0,00 US$ | — |
| OSRH | OSR HEALTH, INC. | D- | — | 0,12 US$ | — | 1,7M US$ | -781,5 % |
| SLBT | SL Science Holding Ltd | sin calificar | — | 0,75 US$ | — | — | — |
| TBPH | Theravance Biopharma, Inc. | C | — | 17,03 US$ | — | 104,3M US$ | 51,6 % |
| VCRE | Vicore Pharma Holding AB | sin calificar | — | 10,63 US$ | — | — | — |
| VRXA | Veraxa Biotech Holding AG | sin calificar | — | 1,12 US$ | — | — | — |
| VTVT | vTv Therapeutics Inc. | C- | — | 19,52 US$ | — | 36,8M US$ | -20,8 % |
Fundamentales de informes ante la SEC, precios de la última pasada de datos de mercado. Ordena por cualquier columna; las empresas sin cifra van al final en ambos sentidos.
Ordenado por capitalización, de mayor a menor; pulsa cualquier columna para reordenar. Las empresas sin cifra van al final en ambos sentidos, porque un PER que falta significa que no hay beneficio y no que esté barata. Nada de esto es una recomendación.